ID   CP4A2_RAT               Reviewed;         504 AA.
AC   P20816; Q4G071;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 2.
DT   24-JUL-2024, entry version 181.
DE   RecName: Full=Cytochrome P450 4A2;
DE   AltName: Full=CYPIVA2;
DE   AltName: Full=Cytochrome P-450 K-2;
DE   AltName: Full=Cytochrome P450 K-5;
DE   AltName: Full=Cytochrome P450-LA-omega 2;
DE   AltName: Full=Lauric acid omega-hydroxylase;
DE   AltName: Full=Long-chain fatty acid omega-monooxygenase;
DE            EC=1.14.14.80 {ECO:0000269|PubMed:1739747};
DE   Flags: Precursor;
GN   Name=Cyp4a2 {ECO:0000303|PubMed:10620324, ECO:0000312|RGD:2479};
GN   Synonyms=Cyp4a-2, Cyp4a11;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=2766932; DOI=10.1089/dna.1.1989.8.503;
RA   Kimura S., Hanioka N., Matsunaga E., Gonzalez F.J.;
RT   "The rat clofibrate-inducible CYP4A gene subfamily. I. Complete intron and
RT   exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organization, and
RT   identification of a conserved 19-bp upstream element.";
RL   DNA 8:503-516(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 5-34.
RC   TISSUE=Kidney;
RX   PubMed=1739747; DOI=10.1016/0005-2760(92)90106-6;
RA   Kawashima H., Kusunose E., Kubota I., Maekawa M., Kusunose M.;
RT   "Purification and NH2-terminal amino acid sequences of human and rat kidney
RT   fatty acid omega-hydroxylases.";
RL   Biochim. Biophys. Acta 1123:156-162(1992).
RN   [4]
RP   PROTEIN SEQUENCE OF 5-19.
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=2306108; DOI=10.1016/0003-9861(90)90747-m;
RA   Imaoka S., Nagashima K., Funae Y.;
RT   "Characterization of three cytochrome P450s purified from renal microsomes
RT   of untreated male rats and comparison with human renal cytochrome P450.";
RL   Arch. Biochem. Biophys. 276:473-480(1990).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=10620324; DOI=10.1006/abbi.1999.1504;
RA   Hoch U., Zhang Z., Kroetz D.L., Ortiz de Montellano P.R.;
RT   "Structural determination of the substrate specificities and
RT   regioselectivities of the rat and human fatty acid omega-hydroxylases.";
RL   Arch. Biochem. Biophys. 373:63-71(2000).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF SER-116, AND PATHWAY.
RX   PubMed=10869363; DOI=10.1074/jbc.m004841200;
RA   Hoch U., Falck J.R., de Montellano P.R.;
RT   "Molecular basis for the omega-regiospecificity of the CYP4A2 and CYP4A3
RT   fatty acid hydroxylases.";
RL   J. Biol. Chem. 275:26952-26958(2000).
RN   [7]
RP   COVALENT HEME ATTACHMENT.
RX   PubMed=11139583; DOI=10.1074/jbc.m009969200;
RA   Hoch U., Ortiz de Montellano P.R.;
RT   "Covalently linked heme in cytochrome P4504A fatty acid hydroxylases.";
RL   J. Biol. Chem. 276:11339-11346(2001).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: A cytochrome P450 monooxygenase that catalyzes omega and
CC       omega-1 hydroxylation of saturated fatty acids. Exhibits preferential
CC       omega versus omega-1 regioselectivity and (R) versus (S)
CC       stereoselectivity for hydroxylation of lauric and myristic acids
CC       (PubMed:10620324, PubMed:10869363). Has low activity toward palmitic
CC       acid (PubMed:10620324). Mechanistically, uses molecular oxygen
CC       inserting one oxygen atom into a substrate, and reducing the second
CC       into a water molecule, with two electrons provided by NADPH via
CC       cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase)
CC       (PubMed:10620324, PubMed:10869363). {ECO:0000269|PubMed:10620324,
CC       ECO:0000269|PubMed:10869363}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an omega-methyl-long-chain fatty acid + O2 + reduced [NADPH--
CC         hemoprotein reductase] = an omega-hydroxy-long-chain fatty acid +
CC         H(+) + H2O + oxidized [NADPH--hemoprotein reductase];
CC         Xref=Rhea:RHEA:56748, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:140991,
CC         ChEBI:CHEBI:140992; EC=1.14.14.80;
CC         Evidence={ECO:0000269|PubMed:1739747};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoate + O2 + reduced [NADPH--hemoprotein reductase] =
CC         (11R)-hydroxydodecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:41724, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:18262, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:78423; Evidence={ECO:0000269|PubMed:10869363};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41725;
CC         Evidence={ECO:0000305|PubMed:10869363};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoate + O2 + reduced [NADPH--hemoprotein reductase] =
CC         12-hydroxydodecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:38947, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:18262, ChEBI:CHEBI:36204, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210; Evidence={ECO:0000269|PubMed:10620324,
CC         ECO:0000269|PubMed:10869363};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38948;
CC         Evidence={ECO:0000305|PubMed:10620324, ECO:0000305|PubMed:10869363};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + reduced [NADPH--hemoprotein reductase] + tetradecanoate =
CC         14-hydroxytetradecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:40203, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30807, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:77033; Evidence={ECO:0000269|PubMed:10620324,
CC         ECO:0000269|PubMed:10869363};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40204;
CC         Evidence={ECO:0000305|PubMed:10620324, ECO:0000305|PubMed:10869363};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoate + O2 + reduced [NADPH--hemoprotein reductase] =
CC         16-hydroxyhexadecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:40199, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:55329, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210; EC=1.14.14.80;
CC         Evidence={ECO:0000269|PubMed:10620324};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40200;
CC         Evidence={ECO:0000305|PubMed:10620324};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:P20817};
CC   -!- PATHWAY: Lipid metabolism; fatty acid metabolism.
CC       {ECO:0000305|PubMed:10620324, ECO:0000305|PubMed:10869363}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane; Peripheral membrane protein.
CC   -!- INDUCTION: By clofibrate.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M57719; AAA41039.1; -; Genomic_DNA.
DR   EMBL; BC078684; AAH78684.1; -; mRNA.
DR   EMBL; BC098705; AAH98705.1; -; mRNA.
DR   PIR; A32965; A32965.
DR   PIR; PC4350; PC4350.
DR   RefSeq; NP_001038235.1; NM_001044770.2.
DR   RefSeq; XP_017448632.1; XM_017593143.1.
DR   AlphaFoldDB; P20816; -.
DR   SMR; P20816; -.
DR   STRING; 10116.ENSRNOP00000074484; -.
DR   SwissLipids; SLP:000000743; -.
DR   iPTMnet; P20816; -.
DR   PaxDb; 10116-ENSRNOP00000042072; -.
DR   Ensembl; ENSRNOT00000111375.1; ENSRNOP00000082696.1; ENSRNOG00000066487.1.
DR   Ensembl; ENSRNOT00000115710.1; ENSRNOP00000088666.1; ENSRNOG00000064139.1.
DR   GeneID; 24306; -.
DR   KEGG; rno:24306; -.
DR   AGR; RGD:2479; -.
DR   AGR; RGD:41366809; -.
DR   CTD; 24306; -.
DR   RGD; 2479; Cyp4a2.
DR   eggNOG; KOG0157; Eukaryota.
DR   GeneTree; ENSGT00940000155173; -.
DR   HOGENOM; CLU_001570_5_1_1; -.
DR   InParanoid; P20816; -.
DR   OMA; ACQIVHE; -.
DR   OrthoDB; 1611592at2759; -.
DR   BRENDA; 1.14.14.80; 5301.
DR   Reactome; R-RNO-211935; Fatty acids.
DR   Reactome; R-RNO-211958; Miscellaneous substrates.
DR   Reactome; R-RNO-211979; Eicosanoids.
DR   Reactome; R-RNO-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   UniPathway; UPA00199; -.
DR   PRO; PR:P20816; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000030154; Expressed in adult mammalian kidney and 14 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0018685; F:alkane 1-monooxygenase activity; IMP:RGD.
DR   GO; GO:0008405; F:arachidonic acid 11,12-epoxygenase activity; TAS:RGD.
DR   GO; GO:0050544; F:arachidonic acid binding; IDA:RGD.
DR   GO; GO:0008391; F:arachidonic acid monooxygenase activity; IMP:RGD.
DR   GO; GO:0005504; F:fatty acid binding; IDA:RGD.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0102033; F:long-chain fatty acid omega-hydroxylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; IMP:RGD.
DR   GO; GO:0046456; P:icosanoid biosynthetic process; IMP:RGD.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0048252; P:lauric acid metabolic process; IDA:RGD.
DR   GO; GO:0043651; P:linoleic acid metabolic process; IDA:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   CDD; cd20678; CYP4B-like; 1.
DR   Gene3D; 1.10.630.10; Cytochrome P450; 1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   InterPro; IPR050196; Cytochrome_P450_Monoox.
DR   PANTHER; PTHR24291:SF47; CYTOCHROME P450 4A14-RELATED; 1.
DR   PANTHER; PTHR24291; CYTOCHROME P450 FAMILY 4; 1.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; Cytochrome P450; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Endoplasmic reticulum; Heme; Iron; Membrane;
KW   Metal-binding; Microsome; Monooxygenase; NADP; Oxidoreductase;
KW   Phosphoprotein; Reference proteome.
FT   PROPEP          1..4
FT                   /evidence="ECO:0000269|PubMed:1739747,
FT                   ECO:0000269|PubMed:2306108"
FT                   /id="PRO_0000003567"
FT   CHAIN           5..504
FT                   /note="Cytochrome P450 4A2"
FT                   /id="PRO_0000003568"
FT   BINDING         315
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /note="covalent"
FT                   /evidence="ECO:0000269|PubMed:11139583"
FT   BINDING         451
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000269|PubMed:11139583"
FT   MOD_RES         434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         116
FT                   /note="S->F: 2-fold decrease of omega/omega-1 hydroxylation
FT                   ratio for lauric acid."
FT                   /evidence="ECO:0000269|PubMed:10869363"
SQ   SEQUENCE   504 AA;  57969 MW;  8A795DD454125287 CRC64;
     MGFSVFSPTR SLDGVSGFFQ GAFLLSLFLV LFKAVQFYLR RQWLLKALEK FPSTPSHWLW
     GHNLKDREFQ QVLTWVEKFP GACLQWLSGS TARVLLYDPD YVKVVLGRSD PKPYQSLAPW
     IGYGLLLLNG KKWFQHRRML TPAFHYDILK PYVKIMADSV SIMLDKWEKL DDQDHPLEIF
     HYVSLMTLDT VMKCAFSHQG SVQLDVNSRS YTKAVEDLNN LIFFRVRSAF YGNSIIYNMS
     SDGRLSRRAC QIAHEHTDGV IKTRKAQLQN EEELQKARKK RHLDFLDILL FAKMEDGKSL
     SDEDLRAEVD TFMFEGHDTT ASGISWVFYA LATHPEHQER CREEVQSILG DGTSVTWDHL
     DQMPYTTMCI KEALRLYSPV PSVSRELSSP VTFPDGRSIP KGIRVTILIY GLHHNPSYWP
     NPKVFDPSRF SPDSPRHSHA YLPFSGGARN CIGKQFAMNE LKVAVALTLL RFELLPDPTR
     IPVPMPRLVL KSKNGIHLRL KKLR
//
